Celularity biomaterial products are manufactured in its state-of-the-art cGMP/cGTP compliant facility located in Florham Park, New Jersey FLORHAM PARK, N.J., May 23, 2023 (GLOBE NEWSWIRE) -- ...
FLORHAM PARK, N.J., May 23, 2023 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (Celularity), a biotechnology company developing placental-derived allogeneic cell therapies and biomaterial ...
Marks an important first step in Celularity’s expansion strategy into the Middle East with a priority focus on the Gulf region, according to Celularity CEO, Dr. Robert Hariri. Celularity biomaterial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results